New: A brand-new, unused, unopened and undamaged item in original retail packaging (where packaging is ... Read moreabout the condition
|MPN:||Does Not Apply|
- Steigbügel Edelstahl mit weißer Einlage FILLIS - NEU
- Outdoor stainless steel windproof wood stove portable oven set
- 2019 Demarini CF ZEN BALANCED (-10) USA 2 5 8 BASEBALL BAT (DXUFX-19)
- New Eureka Copper Canyon 4 Tent Camping Canopy Shelter Outdoor Waterproof
- One Stop Outdoor USA Made Synthetic Grass Landscape, 5.5 Stakes, 40 lb Boxed an
- Scarpa Mojito black Sneaker Schnürschuh Wanderschuh
- Russian Chameleon SVD Dragunov chestrig Digital Flora, brand new
- Kit Tuyau Hydraulique Avid Xx Juteux Ultime, Juteux 7, 5, 2000 Mm, Aluminium -
- BRAND NEW Propulse AC Wimbledon Babolat trainers
- redO GRIP DEFIANT SOUL 15 pounds - New in box
- [ABS] PRO-AM PREMIUM NEW MODEL 2017 ASB 1 BALL MINI BAG PURPLE_Ac
- Maillot Foot Pumas Mexique XL Neuf
- VEST KINGFISHER KAKI 150N MANUAL FORWATER GI515033
- New Balance T4040v4 Men’s 12.5 Turf shoes Navy
- ALPINA Erwachsene GRAP 2.0 L.E. Skihelm - Denim-blueee Matt - Gr. 61-64cm
- Schutt vengeance z10 adult xl orange
University of Iowa Stead Family Children’s Hospital is designed as a healing environment that improves the health and well-being of children and their families. Plans include expanding existing programs and developing new services on-site and throughout Iowa to meet the current and future needs of Iowa’s children.
University of Iowa Stead Family Children’s Hospital joins a group of more than 30 sites across the country committed to using research and education to help prevent injury to children.
Join us on Friday, July 12 at University of Iowa Health Care - Iowa River Landing for a bike safety event geared to the whole family.
Edward Bell, MD, a neonatologist at University of Iowa Stead Family Children’s Hospital, has been awarded the Maureen Andrew Mentor Award from the Society of Pediatric Research, following his 40 years in pediatric medicine.
UI researchers led by Miles Pufall, PhD, have identified a new target that may help improve treatment for children with relapsed B-cell acute lymphoblastic leukemia (B-ALL), the most common type of childhood cancer.